Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Zu‐Guo Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3991-1728; OpenAlex author ID A5077584458. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. High-Dimensional SERS Mapping of Single Circulating Tumor Cells Deciphers the Phenotypic Landscape and Stratifies Metastatic Risk in Pancreatic Cancer. Last author DOI 10.1021/acssensors.6c01742↗
  2. Phellodendrine chloride suppresses proliferation of KRAS mutated pancreatic cancer cells through inhibition of nutrients uptake via macropinocytosis. First author DOI 10.1016/j.ejphar.2019.01.060↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanrong Wen · 1 shared paper, 2026 · strength 0.32
  2. Jian He · 1 shared paper, 2026 · strength 0.32
  3. Pyone Myat Thu · 1 shared paper, 2019 · strength 0.09
  4. Ji Li · 1 shared paper, 2019 · strength 0.09
  5. Ping Li · 1 shared paper, 2019 · strength 0.09
  6. Xiaojun Xu · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.